Related Experiment Video

Updated: Mar 9, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

1.6K

[Bidirectional impact of two chronic diseases: heart failure and diabetes mellitus]

José D Tafur1, Héctor O Ventura2

  • 1Departamento de Enfermedades Cardiovasculares, Instituto Cardiovascular John Ochsner, Escuela de Medicina, Universidad de Queensland, Nueva Orleans, Estados Unidos. Address: Instituto Cardiovascular John Ochsner, Jefferson Highway1514, Nueva Orleans, Estados Unidos.

Medwave
|January 6, 2017
PubMed

Insights

Heart failure and diabetes mellitus are closely linked, with diabetes worsening heart failure outcomes. Understanding this connection is crucial for better patient care and managing these prevalent chronic conditions.

Area of Science:

  • Cardiology
  • Endocrinology
  • Public Health

Background:

  • Heart failure (HF) poses a significant global health burden, with high morbidity and mortality despite medical advancements.
  • Diabetes mellitus (DM) is a well-established risk factor influencing the development and prognosis of heart failure.
  • Current management strategies often address HF and DM in isolation, potentially overlooking critical interactions.

Purpose of the Study:

  • To highlight the significant impact of diabetes mellitus on heart failure development and progression.
  • To emphasize the bidirectional relationship between heart failure and diabetes mellitus.
  • To advocate for integrated management approaches considering the interplay between these two conditions.

Main Methods:

  • Review of existing literature on the comorbidity of heart failure and diabetes mellitus.
  • Analysis of epidemiological data linking diabetes prevalence with heart failure incidence and outcomes.
  • Synthesis of clinical evidence on the impact of diabetes on heart failure pathophysiology and management.

Main Results:

  • Diabetes mellitus significantly increases the risk and exacerbates the severity of heart failure.
  • The presence of diabetes mellitus is associated with poorer prognosis and increased mortality in heart failure patients.
  • The interplay between HF and DM affects treatment efficacy and patient outcomes.

Conclusions:

  • Clinicians must recognize the profound and bidirectional impact of diabetes on heart failure.
  • Integrated care models are essential for optimizing outcomes in patients with comorbid heart failure and diabetes.
  • Further research is warranted to elucidate specific mechanisms and develop targeted therapies for this population.

Keywords:
cardiovascular diseasesdiabetes mellitusmortalityheart failure

More Related Videos

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

704
Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

703

Related Concept Videos

Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.1K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.1K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.3K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
446